Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]

The summary for the Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)] Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]
	CFDA Number:	93.847
	CFDA Description:	Diabetes, Digestive, and Kidney Diseases Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Food and Nutrition Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-DK-10-008
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	May 19, 2010
	Creation Date:	May 19, 2010
	Original Closing Date for Applications:	Nov 29, 2010
	Current Closing Date for Applications:	Nov 29, 2010
	Archive Date:	Dec 30, 2010
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$3,200,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Information not provided
Grant Description: Purpose. This FOA solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward an integrated long term glucose regulated insulin delivery system (artificial pancreas). Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 5-10 projects awarded as a result of this announcement is $ 3.2M for fiscal year 2011. Future year amounts will depend on annual appropriations.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-dk-10-008.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Pediatric Centers of Excellence in Nephrology (P50); • Nutrition Obesity Research Centers (P30); • George M. OBrien Kidney Research Core Centers (P30); • Cooperative Study Group for Autoimmune Disease Prevention (U01); • Collaborative Interdisciplinary Team Science in NIDDK Research Areas (R24); • PROTEOMIC AND METABOLOMIC APPROACHES TO DIAGNOSE DIABETES AND PRE-DIABETES; • MOLECULAR THERAPY CORE CENTERS; • PILOT AND FEASIBILITY PROGRAM IN HUMAN ISLET BIOLOGY; • DIABETES ENDOCRINOLOGY RESEARCH CENTERS; • CYSTIC FIBROSIS RESEARCH AND TRANSLATION CORE CENTERS